Literature DB >> 19336016

Controversies in the management of early-stage germ cell tumors.

Ann Tan1, Timothy Gilligan.   

Abstract

The optimal management of clinical stage I testicular germ cell tumors remains controversial despite a cure rate of 99%. Alternatives for stage I nonseminomas include close surveillance, retroperitoneal lymph node dissection, and chemotherapy. For pure seminomas, the options are surveillance, chemotherapy, and radiation. Understanding the pros and cons of each approach may help in choosing a management plan.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19336016     DOI: 10.1007/s11912-009-0033-3

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  47 in total

1.  Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma--predominant testis cancer.

Authors:  C J Sweeney; B P Hermans; D K Heilman; R S Foster; J P Donohue; L H Einhorn
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

2.  Low-dose radiotherapy for Stage I seminoma--long-term results.

Authors:  Marcus Niewald; Johanna Freyd; Jochen Fleckenstein; Bernd Wullich; Christian Rübe
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-09-18       Impact factor: 7.038

3.  Adjuvant carboplatin in stage I seminoma.

Authors:  Padraig Warde; Mary Gospodarowicz
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

4.  Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.

Authors:  A Heidenreich; I A Sesterhenn; F K Mostofi; J W Moul
Journal:  Cancer       Date:  1998-09-01       Impact factor: 6.860

5.  Stage I seminoma of the testis. Adjuvant radiotherapy or surveillance?

Authors:  E P Allhoff; S Liedke; W de Riese; C Stief; B Schneider
Journal:  Br J Urol       Date:  1991-08

6.  Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?

Authors:  Rauf Taner Divrik; Bülent Akdoğan; Haluk Ozen; Ferruh Zorlu
Journal:  J Urol       Date:  2006-10       Impact factor: 7.450

7.  Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial.

Authors:  R T D Oliver; M D Mason; G M Mead; H von der Maase; G J S Rustin; J K Joffe; R de Wit; N Aass; J D Graham; R Coleman; S J Kirk; S P Stenning
Journal:  Lancet       Date:  2005 Jul 23-29       Impact factor: 79.321

Review 8.  Management of clinical stage I nonseminomatous germ cell testicular cancer.

Authors:  Toni K Choueiri; Andrew J Stephenson; Timothy Gilligan; Eric A Klein
Journal:  Urol Clin North Am       Date:  2007-05       Impact factor: 2.241

Review 9.  European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.

Authors:  Susanne Krege; Jörg Beyer; Rainer Souchon; Peter Albers; Walter Albrecht; Ferran Algaba; Michael Bamberg; István Bodrogi; Carsten Bokemeyer; Eva Cavallin-Ståhl; Johannes Classen; Christoph Clemm; Gabriella Cohn-Cedermark; Stéphane Culine; Gedske Daugaard; Pieter H M De Mulder; Maria De Santis; Maike de Wit; Ronald de Wit; Hans Günter Derigs; Klaus-Peter Dieckmann; Annette Dieing; Jean-Pierre Droz; Martin Fenner; Karim Fizazi; Aude Flechon; Sophie D Fosså; Xavier Garcia del Muro; Thomas Gauler; Lajos Geczi; Arthur Gerl; Jose Ramon Germa-Lluch; Silke Gillessen; Jörg T Hartmann; Michael Hartmann; Axel Heidenreich; Wolfgang Hoeltl; Alan Horwich; Robert Huddart; Michael Jewett; Johnathan Joffe; William G Jones; László Kisbenedek; Olbjørn Klepp; Sabine Kliesch; Kai Uwe Koehrmann; Christian Kollmannsberger; Markus Kuczyk; Pilar Laguna; Oscar Leiva Galvis; Volker Loy; Malcolm D Mason; Graham M Mead; Rolf Mueller; Craig Nichols; Nicola Nicolai; Tim Oliver; Dalibor Ondrus; Gosse O N Oosterhof; Luis Paz Ares; Giorgio Pizzocaro; Jörg Pont; Tobias Pottek; Tom Powles; Oliver Rick; Giovanni Rosti; Roberto Salvioni; Jutta Scheiderbauer; Hans-Ulrich Schmelz; Heinz Schmidberger; Hans-Joachim Schmoll; Mark Schrader; Felix Sedlmayer; Niels E Skakkebaek; Aslam Sohaib; Sergei Tjulandin; Padraig Warde; Stefan Weinknecht; Lothar Weissbach; Christian Wittekind; Eva Winter; Lori Wood; Hans von der Maase
Journal:  Eur Urol       Date:  2007-12-26       Impact factor: 20.096

10.  Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197--the National Cancer Research Institute Testis Cancer Clinical Studies Group.

Authors:  Gordon J Rustin; Graham M Mead; Sally P Stenning; Paul A Vasey; Nina Aass; Robert A Huddart; Michael P Sokal; Jonathan K Joffe; Stephen J Harland; Sarah J Kirk
Journal:  J Clin Oncol       Date:  2007-04-10       Impact factor: 44.544

View more
  1 in total

1.  Oncological Outcomes in Japanese Men Undergoing Orchiectomy for Stage I Testicular Germ Cell Tumor.

Authors:  Ken-Ichi Harada; Hideaki Miyake; Takayoshi Ogawa; Taka-Aki Inoue; Masato Fujisawa
Journal:  Curr Urol       Date:  2015-07-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.